Tag: COPD
CVD Risk Up With β2-Agonist, Antimuscarinic Antagonist Start
New use of long-acting β2-agonists, antimuscarinic antagonists tied to higher CVD risk in first 30 days
FDA Removes Boxed Warning From Certain Asthma Medications
Decision applies to long-acting beta agonists used in combination with inhaled corticosteroids
RA Associated With Higher Risk of COPD Hospitalization
Risk is 47 percent higher in RA patients than general population after adjustment for confounders
LAMA Plus LABA Tied to Fewer Exacerbations in Stable COPD
Also might result in greater improvement in FEV1 than LABA plus corticosteroids
Mepolizumab Beneficial in COPD With Eosinophilic Phenotype
Lower annual rate of moderate, severe exacerbations for patients receiving 100 mg mepolizumab
Statins Tied to Reduced Mortality Risk in COPD
Statin exposure associated with lower all-cause, pulmonary mortality
Airway Mucin Concentrations May Help Predict Chronic Bronchitis
Mean total mucin concentrations up in smokers with severe COPD, those with respiratory exacerbations
Tiotropium Effective in Mild to Moderate COPD
Daily inhaled dose tied to improvements in FEV1 compared to placebo
Worse LV Global Longitudinal Strain for STEMI With COPD
Patients with versus without COPD have more impaired left ventricular global longitudinal strain
Once-Daily Triple-Tx Improves Lung Function, HRQoL in COPD
Significantly improved FEV1 and St. George's Respiratory Questionnaire scores
